Lung Cancer
News
Pemetrexed/Bevacizumab Maintenance Combo Stalls Lung Cancer
Findings: Patients on the combination maintenance therapy had a median progression-free survival of 10.2 months vs.
News
Molecular Profiling Transforming Care of Advanced Lung Cancer
News
Crizotinib Approval Personalizes Lung Cancer Therapy
Article
Personalized medicine: myth to reality
News
NSCLC: FDA Approves Crizotinib, Companion Diagnostic Test
News
Noninvasive Scan Genotypes Non-Small Cell Lung Cancer
Major Finding: Advanced non–small cell lung cancer tumors with an epidermal growth factor receptor (EGFR)–activating mutation bound significantly...
News
Platinum-Based Chemotherapy Benefits Elderly Lung Cancer Patients
Major Finding: By 1 year, median overall survival was 25.4% with monotherapy, vs. 44.5% with a carboplatin and paclitaxel doublet.Data Source: A...
News
Endosonography Bests Surgical Lung Cancer Staging
Major Finding: For patients staged with initial endosonographic assessment of lymph node metastases, quality of life on the EQ-5D surpassed that...
News
VATS, Open Lobectomy Produce Similar Survival in Early Lung Cancer
Major Finding: Patients with early-stage lung cancer who underwent VATS had a 72% 5-year overall survival rate, statistically similar to the 66%...
Article
The old and the new
News
Stereotactic Radiation Gives Elderly Lung Cancer Patients an Alternative to Surgery
Major Finding: Elderly Dutch patients who underwent radiation therapy during 2007-2009 had a median overall survival of 26 months vs.